Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Breast Cancer Research and Treatment
Erschienen in: Breast Cancer Research and Treatment 3/2017

01.04.2017 | Review

Prognosis of pregnancy-associated breast cancer

verfasst von: Guek Eng Lee, Erica L. Mayer, Ann Partridge

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Conventionally, breast cancer diagnosed during pregnancy and within the years following have been referred to collectively as pregnancy-associated breast cancer. However, increasing evidence suggests that breast cancer diagnosed during pregnancy is a different entity from that diagnosed postpartum, both in terms of prognosis and biology. Given the increasing number of women who find themselves diagnosed with breast cancer during or following a pregnancy, future research and discussion should separate these two into distinct groups: breast cancer diagnosed during pregnancy and breast cancer diagnosed postpartum in an effort to enhance our understanding to inform and improve clinical management and counseling.
Literatur
1.
Smith LH et al (2003) Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 189(4):1128–1135CrossRefPubMed
2.
Van Calsteren K et al (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28(4):683–689CrossRefPubMed
3.
Andersson TM et al (2009) Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol 114(3):568–572CrossRefPubMed
4.
Raphael J, Trudeau ME, Chan K (2015) Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature. Curr Oncol 22(Suppl 1):S8–S18PubMedPubMedCentral
5.
Abenhaim HA et al (2012) Incidence, risk factors, and obstetrical outcomes of women with breast cancer in pregnancy. Breast J 18(6):564–568CrossRefPubMed
6.
Schedin P (2006) Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6(4):281–291CrossRefPubMed
7.
Vinatier E et al (2009) Breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 147(1):9–14CrossRefPubMed
8.
9.
10.
11.
Amant F et al (2013) Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 31(20):2532–2539CrossRefPubMed
12.
Azim HA Jr et al (2012) The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study. Acta Oncol 51(5):653–661CrossRefPubMed
13.
Azim HA Jr et al (2012) Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev 38(7):834–842CrossRefPubMed
14.
Litton JK et al (2013) Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist 18(4):369–376CrossRefPubMedPubMedCentral
15.
Ezzat A et al (1996) Impact of pregnancy on non-metastatic breast cancer: a case control study. Clin Oncol (R Coll Radiol) 8(6):367–370CrossRef
16.
Greene FL (1988) Gestational breast cancer: a ten-year experience. South Med J 81(12):1509–1511CrossRefPubMed
17.
Guinee VF et al (1994) Effect of pregnancy on prognosis for young women with breast cancer. Lancet 343(8913):1587–1589CrossRefPubMed
18.
Ibrahim EM et al (2000) Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol 17(4):293–300CrossRefPubMed
19.
20.
Stensheim H et al (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27(1):45–51CrossRefPubMed
21.
22.
Hartman EK, Eslick GD (2016) The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis. Breast Cancer Res Treat 160(2):347–360CrossRefPubMed
23.
Amant F et al (2010) Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 46(18):3158–3168CrossRefPubMed
24.
Loibl S et al (2006) Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106(2):237–246CrossRefPubMed
25.
O’Neill AC, DiPiro PJ, Mayer EL (2016) Staging workup in pregnant cancer patients, in managing cancer during pregnancy. In: Azim HA Jr (ed). Springer, New York, pp 17–28
26.
Callihan EB et al (2013) Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat 138(2):549–559CrossRefPubMedPubMedCentral
27.
Johansson AL et al (2011) Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 20(9):1865–1872CrossRefPubMed
28.
Daling JR et al (2002) The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev 11(3):235–241PubMed
29.
Whiteman MK et al (2004) Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 104(1):146–154CrossRefPubMed
30.
31.
Barnett GC et al (2008) Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol 26(20):3310–3316CrossRefPubMed
32.
Asztalos S et al (2010) Gene expression patterns in the human breast after pregnancy. Cancer Prev Res (Phila) 3(3):301–311CrossRef
33.
Atabai K, Sheppard D, Werb Z (2007) Roles of the innate immune system in mammary gland remodeling during involution. J Mammary Gland Biol Neoplasia 12(1):37–45CrossRefPubMedPubMedCentral
34.
Clarkson RW et al (2000) NF-kappaB inhibits apoptosis in murine mammary epithelia. J Biol Chem 275(17):12737–12742CrossRefPubMed
35.
Clarkson RW et al (2004) Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 6(2):R92–R109CrossRefPubMed
36.
Lyons TR et al (2014) Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer. J Clin Investig 124(9):3901–3912CrossRefPubMedPubMedCentral
37.
Lyons TR et al (2011) Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17(9):1109–1115CrossRefPubMedPubMedCentral
38.
Monks J et al (2002) Do inflammatory cells participate in mammary gland involution? J Mammary Gland Biol Neoplasia 7(2):163–176CrossRefPubMed
39.
O’Brien J, Schedin P (2009) Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer? J Mammary Gland Biol Neoplasia 14(2):145–157CrossRefPubMedPubMedCentral
40.
Schedin P et al (2004) Mammary ECM composition and function are altered by reproductive state. Mol Carcinog 41(4):207–220CrossRefPubMed
41.
Borges V, Elder A, Lyons T (2016) Deciphering pro-lymphangiogenic programs during mammary involution and postpartum breast cancer. Front Oncol 6(227)
42.
43.
Borges VF et al (2015) Abstract P6-08-08: postpartum breast cancer demonstrates increased liver and brain metastasis with a proposed role for postpartum involution. Cancer Res 75(9 Supplement):P6–08-08-P6-08-08
44.
Collins LC et al (2015) Molecular phenotype of breast cancer according to time since last pregnancy in a large cohort of young women. Oncologist 20(7):713–718CrossRefPubMedPubMedCentral
Metadaten
Titel
Prognosis of pregnancy-associated breast cancer
verfasst von
Guek Eng Lee
Erica L. Mayer
Ann Partridge
Publikationsdatum
01.04.2017
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2017
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4224-6

Weitere Artikel der Ausgabe 3/2017

Breast Cancer Research and Treatment 3/2017 Zur Ausgabe

Preclinical study

Immunoglobulin-like domain 4-mediated ligand-independent dimerization triggers VEGFR-2 activation in HUVECs and VEGFR2-positive breast cancer cells

Epidemiology

Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer

Erratum

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

Erratum

Erratum to: ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling

Brief Report

Aromatase expression in atypical ductal hyperplasia in women

Preclinical study

ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise